Showing results (1-10 of 870) with videos related to

Sort By:
Pageof 87
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 5, 2019
Obesity Paradox in Atrial Fibrillation: Implications for Outcomes and Relationship with Oral Anticoagulant DrugsMarco Proietti, Giuseppe Boriani
Heart (British Cardiac Society)|December 2, 2017
Atrial fibrillation prevention: an appraisal of current evidenceGiuseppe Boriani, Marco Proietti
Therapeutics and Clinical Risk Management|September 4, 2018
Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisalMarco Proietti, Giuseppe Boriani
Drugs|June 7, 2020
Edoxaban and the Issue of Drug-Drug Interactions: From Pharmacology to Clinical PracticeAlberto Corsini, Nicola Ferri, Marco Proietti, et al.
The Canadian Journal of Cardiology|April 30, 2019
Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International GuidelinesMarco Proietti, Deirdre A Lane, Giuseppe Boriani, et al.
Biomedicines|August 6, 2021
Clinical Phenotype Classification of Atrial Fibrillation Patients Using Cluster Analysis and Associations with Trial-Adjudicated OutcomesMarco Vitolo, Marco Proietti, Alena Shantsila, et al.
Expert Review of Medical Devices|March 13, 2020
Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulationsJacopo F Imberti, Marco Vitolo, Marco Proietti, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 20, 2016
'Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot PhaseMarco Proietti, Cécile Laroche, Grzegorz Opolski, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 23, 2021
Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term RegistryMarco Proietti, Giulio Francesco Romiti, Marco Vitolo, et al.
European Journal of Internal Medicine|January 28, 2024
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?Giuseppe Boriani, Luigi Gerra, Davide A Mei, et al.
Pageof 87